News

UnoVins to Exhibit at CES 2026,
Expanding Global Reach with “UNOCARE”

Photos from UNOCARE’s participation in CES 2026

Digital health tech company UnoVins announced that it will participate in CES 2026, the world’s largest consumer electronics and IT exhibition, to be held in Las Vegas, USA, exhibiting at the Venetian Expo & Convention Center (Level 2), Halls C (Booth No. 54000).

UnoVins will operate an independent booth from January 6 to 9, showcasing its digital healthcare platform UNOCARE along with its contactless and non-invasive biosignal measurement technologies, as it accelerates its expansion into the global healthcare market.

The company previously participated in MEDICA 2025 in Düsseldorf, Germany, one of the world’s largest medical device exhibitions, where it received strong interest from global buyers and visitors. UnoVins has since been strengthening partnerships, particularly with buyers from China and Indonesia.

Despite being a young digital health startup, UnoVins achieved a rare milestone by winning two CES 2026 Innovation Awards, selected by the Consumer Technology Association (CTA), the organizer of CES. Its mobile app UNO CARE and medical device kiosk UNO BrainBody were both recognized, marking an uncommon achievement for a startup to be awarded in both software and hardware categories.

The UNO BrainBody, which won in the Embedded Technologies category, is a medical-grade kiosk that simultaneously measures electroencephalogram (EEG) and photoplethysmogram (PPG) signals. Using an EEG sensor attached to the forehead and a fingertip PPG sensor, the device precisely assesses brain function and blood flow. It is integrated with more than 30 standardized psychological assessments to objectively evaluate mental health conditions.

The system generates key indicators including autonomic nervous system balance, heart rate variability (HRV), vascular health metrics derived from pulse waveform analysis, frontal lobe activity balance, composite stress indices, and cognitive function assessments based on EEG patterns. Certified under medical device GMP standards, UNO BrainBody is currently deployed at over 200 locations, including hospitals, public institutions, and corporate wellness centers.

The UNO CARE app, which won in the Mobile Devices, Accessories & Apps category, applies remote photoplethysmography (rPPG) technology to measure biosignals using only a smartphone’s front-facing camera. Without the need for wearables or external sensors, users can monitor heart rate, stress levels, and autonomic balance in real time, and receive personalized training programs and healing content based on measured data.

A UnoVins spokesperson said, “Through CES 2026, we aim to further demonstrate our global competitiveness,” adding, “We will continue to set new standards in digital healthcare and strengthen our presence in the global market through our proprietary technologies.”

UnoVins’ CES 2026 booth will be located on the second floor of the Venetian Expo, Halls C (Venetian Expo & Convention Center, Level 2), Booth No. 54000, featuring dedicated spaces for buyer and investor meetings as well as hands-on product demonstrations.